PeptideDB

QMT-CBT

CAS: F: C94H89N19O12S4 W: 1805.09

QMT-CBT is a near-infrared aggregation-induced luminescent photon. After activation of caspase1 (Cas1), QMT-CBT undergoe
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity QMT-CBT is a near-infrared aggregation-induced luminescent photon. After activation of caspase1 (Cas1), QMT-CBT undergoes a CBT-Cys click reaction to form a cyclic dimer QMT-Dimer (the first aggregate) and assembles into nanoparticles (the second aggregate), turning the AIE signal "on" to enhance imaging of Alzheimer's disease (AD)[1].
Sequence Ac-Trp-Glu-His-Asp-{Cys(StBu)}-{Pra(QMT)}-CBT
Shortening Ac-WEHD-{Cys(StBu)-{Pra(QMT)}-CBT
Formula C94H89N19O12S4
Molar Mass 1805.09
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Xu L, et al. Dual Aggregations of a Near-Infrared Aggregation-Induced Emission Luminogen for Enhanced Imaging of Alzheimer's Disease. J Am Chem Soc. 2023 Dec 20;145(50):27748-27756.